March 22-25, 2021
Virtual Event
Connect with us at this year’s digital BIO-EUROPE SPRING and use the event’s One-on-One Partnering to e-meet with Thomas Schirrmann (CEO) and David Passmore (Business Development). Learn more about YUMAB’s fully human antibody technology platform, its potential in drug discovery and development, and the company’s diverse business opportunities. Arrange a meeting
People attending from YUMAB:
Thomas Schirrmann, PhD
CEO & Founder
David Passmore, PhD
Business Development
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17
